Hinesh Upadhyay, MD
Pulmonary Disease · East Orange, NJNPI 1144632944
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.3% of the total across 37 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $197 and has fallen 81.9% since, to $36 in 2025. That places this record below the midpoint for pulmonary disease clinicians in NJ, where the typical reported total is $2,135.
Across 37 payments — averaging $14.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$121
- Boehringer Ingelheim$100
- Mylan Specialty L.p.$45
- Inspire Medical Systems, Inc.$45
- AstraZeneca$39
- E.r. Squibb & Sons, L.L.C.$39
- plus $138 from 8 others
What the payments were for
- Food & beverage$49694%
- Education$306%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 9 | $121 |
| Boehringer Ingelheim | 7 | $100 |
| Mylan Specialty L.p. | 3 | $45 |
| Inspire Medical Systems, Inc. | 2 | $45 |
| AstraZeneca | 3 | $39 |
| E.r. Squibb & Sons, L.L.C. | 3 | $39 |
| Merck | 2 | $25 |
| Sunovion Pharmaceuticals Inc. | 2 | $24 |
| Itamar Medical Inc | 1 | $18 |
| Insmed, Inc. | 1 | $17 |
| Sanofi | 1 | $14 |
| Shire North American Group Inc | 1 | $13 |
| Johnson & Johnson | 1 | $13 |
| Novartis | 1 | $13 |
How this compares
$526 in reported general payments places this provider in the 25th percentile of 472 pulmonary disease providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in East Orange
- Jeffrey MillerEast Orange$14K
- Joseph HoffmanPark Ridge$1.1M
- Reynold PanettieriNew Brunswick$1M
- Robert SussmanSummit$551K
- Manuel CunananMillville$489K
- Emanuele SantomauroHackensack$420K
- Richard MillerNewark$328K
- Jason ShatkinParamus$282K
- Anthony RickettiTrenton$225K
- Jeffrey MiskoffManasquan$176K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.